These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11358283)
1. Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice. Alcaraz-Zubeldia M; Rojas P; Boll C; Rios C Neurochem Res; 2001 Jan; 26(1):59-64. PubMed ID: 11358283 [TBL] [Abstract][Full Text] [Related]
2. Participation of manganese-superoxide dismutase in the neuroprotection exerted by copper sulfate against 1-methyl 4-phenylpyridinium neurotoxicity. Alcaraz-Zubeldia M; Montes S; Ríos C Brain Res Bull; 2001 May; 55(2):277-9. PubMed ID: 11470327 [TBL] [Abstract][Full Text] [Related]
3. Induction of ferroxidase enzymatic activity by copper reduces MPP+-evoked neurotoxicity in rats. Rubio-Osornio M; Montes S; Heras-Romero Y; Guevara J; Rubio C; Aguilera P; Rivera-Mancia S; Floriano-Sánchez E; Monroy-Noyola A; Ríos C Neurosci Res; 2013 Mar; 75(3):250-5. PubMed ID: 23298529 [TBL] [Abstract][Full Text] [Related]
4. S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. Rojas P; Serrano-García N; Medina-Campos ON; Pedraza-Chaverri J; Maldonado PD; Ruiz-Sánchez E J Nutr Biochem; 2011 Oct; 22(10):937-44. PubMed ID: 21190833 [TBL] [Abstract][Full Text] [Related]
5. Copper sulfate prevents tyrosine hydroxylase reduced activity and motor deficits in a Parkinson's disease model in mice. Alcaraz-Zubeldia M; Boll-Woehrlen MC; Montes-López S; Pérez-Severiano F; Martínez-Lazcano JC; Díaz-Ruiz A; Ríos C Rev Invest Clin; 2009; 61(5):405-11. PubMed ID: 20184101 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the antiapoptotic effect of copper sulfate on striatal and midbrain damage induced by MPP Islas-Cortez M; Rios C; Rubio-Osornio M; Zamudio S; Orozco-Suarez S; Mendez-Armenta M; Nava-Ruiz C; Diaz-Ruiz A Neurotoxicology; 2021 Jan; 82():18-25. PubMed ID: 33127410 [TBL] [Abstract][Full Text] [Related]
8. The neuroprotective effect of lovastatin on MPP(+)-induced neurotoxicity is not mediated by PON2. Aguirre-Vidal Y; Montes S; Tristan-López L; Anaya-Ramos L; Teiber J; Ríos C; Baron-Flores V; Monroy-Noyola A Neurotoxicology; 2015 May; 48():166-70. PubMed ID: 25842176 [TBL] [Abstract][Full Text] [Related]
9. Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats. Banerjee R; Saravanan KS; Thomas B; Sindhu KM; Mohanakumar KP Neurochem Res; 2008 Jun; 33(6):985-95. PubMed ID: 17763941 [TBL] [Abstract][Full Text] [Related]
10. MK-801 partially protects against the acute MPP+ depleting effect on dopamine levels in rat striatal slices. Venero JL; Santiago M; Machado A; Cano J Neurochem Int; 1996 Oct; 29(4):411-6. PubMed ID: 8939450 [TBL] [Abstract][Full Text] [Related]
11. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
12. Copper sulfate pretreatment prevents mitochondrial electron transport chain damage and apoptosis against MPP Rubio-Osornio M; Orozco-Ibarra M; Díaz-Ruiz A; Brambila E; Boll MC; Monroy-Noyola A; Guevara J; Montes S; Ríos C Chem Biol Interact; 2017 Jun; 271():1-8. PubMed ID: 28442376 [TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Sairam K; Saravanan KS; Banerjee R; Mohanakumar KP Brain Res; 2003 Mar; 966(2):245-52. PubMed ID: 12618347 [TBL] [Abstract][Full Text] [Related]
14. Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+. Barc S; Page G; Barrier L; Huguet F; Fauconneau B Brain Res; 2002 Jun; 941(1-2):72-81. PubMed ID: 12031549 [TBL] [Abstract][Full Text] [Related]
15. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Cosi C; Marien M Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136 [TBL] [Abstract][Full Text] [Related]